subscribeSubscribe
Acorda’s awful bad week gets worse as FDA hands execs another delay on Inbrija

Acorda’s awful bad week gets worse as FDA hands execs another delay on Inbrija
John Carroll ENDPTS
13 Sep 2018
Share Share
U.S. appeals court invalidates Acorda patents on MS drug

U.S. appeals court invalidates Acorda patents on MS drug
Jan Wolfe CNBC
11 Sep 2018
Share Share
Acorda shares crater after court dashes hopes for salvaging Ampyra patents

Acorda shares crater after court dashes hopes for salvaging Ampyra patents
John Carroll ENDPTS
10 Sep 2018
Share Share
Acorda inks Ampyra generic pacts as Ampyra appeal pends

Acorda inks Ampyra generic pacts as Ampyra appeal pends
Carly Helfand FIERCE PHARMA
06 Aug 2018
Share Share
After resisting a push to the auction block, Acorda shares shoot up

After resisting a push to the auction block, Acorda shares shoot up
John Carroll END POINTS
05 Jan 2018
Share Share
Troubled Acorda hurries to bar the door against a takeover attempt

Troubled Acorda hurries to bar the door against a takeover attempt
John Carroll ENDPTS
02 Sep 2017
Share Share
FDA derails Acorda’s marketing pitch, creating crisis as flagship drug founders

FDA derails Acorda’s marketing pitch, creating crisis as flagship drug founders
John Carroll ENDPTS
29 Aug 2017
Share Share
Ampyra® (Dalfampridine): Acorda Therapeutics, Inc. V. Micro Labs

Ampyra® (Dalfampridine): Acorda Therapeutics, Inc. V. Micro Labs
PATENT LITIGATION
24 May 2017
Share Share
Patent challenger Bass wins another review bid, this time on Acorda`s Ampyra

Patent challenger Bass wins another review bid, this time on Acorda`s Ampyra
Carly Helfand FIERCE PHARMA
14 Mar 2016
Share Share
Catalyst hits an FDA roadblock with its `breakthrough` rare disease drug

Catalyst hits an FDA roadblock with its `breakthrough` rare disease drug
Damian Garde FIERCE BIOTECH
18 Feb 2016
Share Share